Business Wire

EKOS Corporation Supports the Dutch Randomized Trial Comparing Standard Catheter Directed Thrombolysis vs. Ultrasound Accelerated Thrombolysis for Thrombo-Embolic Infra ...

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that EKOS and their Netherlands distributor, AngioCare BV, are supporting a Dutch multicentre randomized trial (DUET) designed to ...
FiercePharma

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions EKOS Corporation, a privately ...
HeraldNet

Ekos ready to go global

BOTHELL – Ekos Corp., which has spent more than a decade inventing ultrasound-enhanced catheters that can quickly break up blood clots, is ready to sell the device to doctors around the world. The ...
Healio

OPTALYSE PE: Catheter-directed thrombolysis system effective in acute PE, even in lower doses

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — In patients with acute submassive pulmonary embolism, treatment with tissue plasminogen ...
Healio

Catheter-assisted thrombolysis safe, effective for patients with DVT, postthrombotic syndrome

Please provide your email address to receive an email when new articles are posted on . Patients with chronic deep vein thrombosis and postthrombotic syndrome can be treated safely and effectively ...
TCTMD

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

Ultrasound-assisted thrombolysis was no better than standard catheter-directed delivery of alteplase when it came to clearing thrombus in patients with submassive pulmonary embolism (PE) in the SUNSET ...
Medscape

Advances in Revascularization for Acute Ischemic Stroke Treatment

Mechanical clot disruption may be achieved by using several different techniques. In order to increase the efficacy of thrombolytic therapy, physicians often try to macerate the thrombus in order to ...
TCTMD

EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism

BOTHELL, Wash.-- EKOS Corporation announced today the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, ...
Business Wire

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...